ANX Financial Facts
Interest income: 31KDepreciation and amortization: 24K
See Full Income Statement
Total assets: 40.12M
Accounts payable: 1.5M
See Full Balance Sheet
Adventrx Pharmaceuticals, Inc. (ANX) Earnings
|
Expand Research on ANX
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +25.0% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -24.2% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/7/11 | Q311 | -$0.13 | -$0.13 | $0.00 | N/A | N/A | N/A | Details | |||
3/7/12 | Q411 | -$0.06 | -$0.09 | +$0.03 | N/A | N/A | N/A | Details | |||
3/10/11 | Q410 | -$0.15 | -$0.18 | +$0.03 | N/A | N/A | N/A | Details | |||
5/7/12 | Q112 | -$0.09 | N/A | N/A | N/A | N/A | N/A | Details | |||
11/5/12 | Q312 | -$0.07 | N/A | N/A | N/A | N/A | N/A | Details | |||
5/9/11 | Q111 | -$0.13 | -$0.26 | +$0.13 | N/A | N/A | N/A | Details | |||
8/6/12 | Q212 | $0.09 | N/A | N/A | N/A | N/A | N/A | Details |